Company Kahira Pharmaceuticals&Chemical Industrs Egyptian Exchange

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Company contact information

Sector

Sector Other Pharmaceuticals

End-of-day quote Egyptian Exchange Other stock markets
-	-

2023	Kahira Pharmaceuticals & Chemical Industries Company Reports Earnings Results for the First Quarter Ended September 30, 2023	CI
2023	Kahira Pharmaceuticals & Chemical Industries Company Reports Earnings Results for the Full Year Ended June 30, 2023	CI

Cairo Pharmaceuticals specializes in manufacturing and marketing pharmaceutical products for the treatment of inflammatory, infectious, pulmonary, parasitic, dermatological, cardiovascular, allergic diseases, etc. The group also provides veterinary products.

EGP in Million	2018	Weight	2019	Weight	Delta
Pharmaceutical Products 100.0 %	863	100.0 %	963	100.0 %	+11.59%

EGP in Million	2018	Weight	2019	Weight	Delta
Egypt 100.0 %	863	100.0 %	963	100.0 %	+11.59%

Managers	Title	Age	Since
Yasser Ahmed Farghaly Mohammad CEO	Chief Executive Officer	-	21-06-01
Ahmed Hassan Sabri DFI	Director of Finance/CFO	-	-
Medhat Mohammed Hazeen SEC	Corporate Secretary	-	-
Hanan Issa Mohamed Abdul Salam IRC	Investor Relations Contact	-	-

Members of the board	Title	Age	Since
Adel Taha Abdel Wahab CHM	Chairman	-	21-06-01
Yasser Ahmed Farghaly Mohammad CEO	Chief Executive Officer	-	21-06-01
Dina Ismail Ahmed Al Kayyali BRD	Director/Board Member	-	21-06-01
Mohammad Abdel Moati Metwally BRD	Director/Board Member	-	21-06-01
Salem Mohammad Jadallah BRD	Director/Board Member	-	21-06-01

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	14,934,375	2,766,942 ( 18.53 %)	0	18.53 %

Cairo Pharmaceuticals

4 Abdel Hamid El-Deeb Street Victoria Square

11672, Cairo

http://www.kahira-pharma.com

address Kahira Pharmaceuticals&Chemical Industrs

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

	1st Jan change	Capi.
ELI LILLY AND COMPANY	+34.00%	704B
NOVO NORDISK A/S	+29.29%	577B
JOHNSON & JOHNSON	-7.75%	348B
MERCK & CO., INC.	+18.53%	327B
ABBVIE INC.	+4.95%	288B
ASTRAZENECA PLC	+13.79%	234B
NOVARTIS AG	+4.93%	198B
ROCHE HOLDING AG	-9.78%	194B
AMGEN INC.	-4.89%	147B

Other Pharmaceuticals